Get started
Author

Morteza Raeisi

Observed names: M. Raeisi, Raeisi, Morteza
Institution: Fondation ARCAD
ORCID: 0000-0002-9999-4097
Observed ORCID: 0000-0002-9999-4097
OpenAlex ID: A5062021439
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
2024 · Romain Cohen, Morteza Raeisi, et al. · European Journal of Cancer · 22
PDF
A spatio-temporal multi-scale model for Geyer saturation point process: Application to forest fire occurrences
2021 · Morteza Raeisi, Florent Bonneu, et al. · Spatial Statistics · 19
PDF
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis
2024 · Benoist Chibaudel, Morteza Raeisi, et al. · Journal of Clinical Oncology · 11
PDF
Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database
2025 · Jean-Baptiste Bachet, Aimery de Gramont, et al. · Journal of Clinical Oncology · 10
A synthetic control arm for refractory metastatic colorectal cancer: the no placebo initiative
2023 · Takayuki Yoshino, Qian Shi, et al. · Nature Medicine · 10
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
2023 · Romain Cohen, Morteza Raeisi, et al. · Journal of Clinical Oncology · 8
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation
2024 · Romain Cohen, Morteza Raeisi, et al. · European Journal of Cancer · 7
Some Dependencies, Stochastic Orders and Aging Properties in an Extended Additive Hazards Model
2016 · M. Raeisi, Gh. Yari · Iranian Journal of Science and Technology Transactions A Science · 4
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis
2025 · R. Cohen, M. Raeisi, et al. · ESMO Open · 3
On spatial and spatio-temporal multi-structure point process models
2020 · Raeisi, Morteza, Bonneu, Florent, et al. · arXiv (Cornell University) · 3
PDF
Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer: An analysis of 18,041 patients in the ARCAD CRC database
2026 · Anna Dorothea Wagner, Morteza Raeisi, et al. · European Journal of Cancer · 2
ARCAD-Asia initiative: leveraging yesterday’s data for tomorrow
2023 · Y. Takeda, T. Misumi, et al. · ESMO Gastrointestinal Oncology · 2
A Spatio-Temporal Hybrid Strauss Hardcore Point Process for Forest Fire Occurrences
2021 · Morteza Raeisi, Florent Bonneu, et al. · Research Square · 2
PDF
Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-derived external control arms
2026 · Morteza Raeisi, Thierry André, et al. · JNCI Journal of the National Cancer Institute
Prognostic Value of Liver Metastases and KRAS Mutations in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Third-Line Placebo-Controlled Trials From the ARCAD CRC Database
2026 · Thomas Samaille, Morteza Raeisi, et al. · Clinical Colorectal Cancer
Prediction of chemotherapy free interval (CFI) after induction chemotherapy in metastatic colorectal cancer (mCRC) based on a meta-analysis on ARCAD database: the CFI PREDICT project
2026 · Marie Muller, Guus M. Bol, et al. · SSRN Electronic Journal
793P Prediction of chemotherapy free interval (CFI) after induction chemotherapy metastatic colorectal cancer (mCRC) based on a meta-analysis on ARCAD database: The CFI PREDICT project
2025 · M. Muller, G. BOL, et al. · Annals of Oncology
PDF
744P Validating ARCAD-Derived external control arms via virtual replication of mCRC randomized trials
2025 · M. Raeisi, T. André, et al. · Annals of Oncology
TWICE-IRI: A Randomized Phase III Study Comparing Modified FOLFIRI3-Aflibercept to FOLFIRI-Aflibercept as Second-Line Therapy in Patients with Metastatic Colorectal Cancer
2025 · Benoist Chibaudel, Olivier Dubreuil, et al. · SSRN Electronic Journal
531P Prognostic value of liver metastases, KRAS mutations and race in colorectal cancer patients: A pooled analysis of third-line placebo-controlled trials from the ARCAD database
2024 · T. André, M. Raeisi, et al. · Annals of Oncology
PDF
7P Molecular targeted therapies based on metastatic site in first-line treatment for colorectal cancer patients: An ARCAD pooled analysis
2024 · M. Raeisi, R. Cohen, et al. · ESMO Open
Twice-Iri: A Randomized Phase Iii Study Comparing Modified Folfiri3-Aflibercept to Folfiri-Aflibercept as Second-Line Therapy in Patients with Metastatic Colorectal Cancer
2024 · Benoist Chibaudel, Olivier Dubreuil, et al. · SSRN Electronic Journal
Bevacizumab in first-line therapy in lung metastases of colorectal cancer: An ARCAD pooled analysis.
2023 · Einat S Shmueli, Morteza Raeisi, et al. · Journal of Clinical Oncology
Using T stage to predict outcomes of adjuvant oxaliplatin (OX)-based chemotherapy (CT) in stage III colon cancer (CC): An ACCENT pooled analysis.
2022 · Romain Cohen, Morteza Raeisi, et al. · Journal of Clinical Oncology
SO-22 Clinical classification-based evaluation of adjuvant therapy with oxaliplatin in stage II colon cancer
2022 · B. Chibaudel, M. Raeisi, et al. · Annals of Oncology
Works count: 27
Citation count: 103
H-index: 7
I10-index: 5
Year
Topic
Type